{"filings":[{"id":1000240,"accession_number":"0001193125-26-267550","cik":1657677,"company_name":"Parabilis Medicines, Inc.","ticker":"PBLS","form_type":"8-K","filed_at":"2026-06-11T20:12:52+00:00","items":["1.01","3.02","5.03","9.01"],"status":"ready","headline":"Regeneron invests $75M in Parabilis at 10% discount to IPO price in concurrent private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchased 4,166,666 shares at 90% of $20 IPO price ($18/share); total $75M.","Private placement closed June 11, 2026, alongside IPO.","Regeneron granted piggyback registration rights on the shares.","Charter amended to authorize 600M voting and 200M non-voting common shares, eliminate preferred.","Transaction signals strategic backing from a major biopharma partner."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":null,"market_cap_as_of_date":null,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}